COA Process

Understanding Certificate of Analysis (COA) Standards

Ensuring Quality and Transparency in Peptide Testing

At Pure Health Peptides, we recognize the importance of reliable and trustworthy products for research purposes. Our commitment to quality extends beyond our peptides to the meticulous processes we use to verify their integrity. By working closely with our partners and understanding key testing criteria, we ensure that our products meet the highest standards, setting us apart from others in the industry.

1. Why Are COAs Important?

A Certificate of Analysis is a document that confirms the identity, purity, and quality of a peptide. It ensures that the product meets specific standards, making it critical for research integrity. Unfortunately, many COAs in the market are incomplete, lack critical data, or fail to meet industry standards, leaving researchers with unreliable results.

2. Differences Between High-End and Generic Testing

High-End Testing Methods and Equipment:

HPLC (High-Performance Liquid Chromatography) – MZ Biolabs: HPLC is used by advanced laboratories to separate components of a peptide to detect even trace impurities with exceptional precision. Various detectors are used with HPLC including the popular UV detectors and mass spectrometers.
UPLC (Ultra-Performance Liquid Chromatography) – Bio Regen
UPLC is an advanced chromatographic technique that builds on HPLC by offering:
- - Higher resolution and sharper peaks for enhanced impurity separation.
  - Increased sensitivity, allowing for more precise low-level impurity detection.
  - Faster analysis times, improving throughput while maintaining accuracy.

By incorporating both HPLC and UPLC methodologies, our testing partners ensure the highest level of analytical precision, setting a benchmark for peptide purity verification

UV Radiation Testing: Both HPLC and UPLC use UV absorption technology to detect impurities in peptide formulations. Chromatograms generated from UV detectors provide a visual representation of compound separation, confirming purity levels and the presence of any contaminants.
Mass Spectrometry (MS): Molecular Identity Confirmation
To further validate peptide composition, samples undergo mass spectrometry testing, ensuring molecular weights precisely match expected values. MS analysis, performed alongside HPLC or UPLC, confirms the authenticity and integrity of the compound.

Generic Testing Methods
Many low-cost-, non-standardized- or non-GMP certified peptide suppliers use outdated, generic methods that fail to ensure accuracy, leading to inconsistent or misleading purity claims by using generic methods, such as:

Titration: A basic method for concentration determination, with limited ability to detect impurities.
Infrared Spectroscopy (IR): Identifies molecular bonds but lacks precision for complex peptide analysis.
Thin-Layer Chromatography (TLC): Useful for basic compound identification but inadequate for low-level impurity detection.

Processes and Procedures

High-End Labs: Use sophisticated equipment, rigorous quality controls, and highly trained professionals. These ensure precision, reliability, and transparency in testing.
Generic Labs: May rely on outdated techniques, simplified procedures, or limited expertise, increasing the risk of incomplete or inaccurate results.

3. How to Read and Interpret a COA

Key Data to Look For

Testing Methodology: Verify that the COA specifies high-end methods like HPLC, UV radiation testing, and MS. These methods ensure the highest level of precision and reliability.
Purity
Percentage: Check for clear reporting of purity levels, ideally supported by chromatograms and impurity breakdowns.
Chromatograms: Look for graphs that illustrate the separation of compounds, showing distinct peaks corresponding to the peptide being tested. Peaks should be labeled with time and area percentages.
Identity Confirmation: Ensure the molecular weight of the compound matches the expected value. For example, mass spectrometry data should provide both expected and measured monoisotopic masses.
Certifying Authority: Confirm that the COA is signed by a qualified chemist or analyst, adding credibility and accountability to the results.

Red Flags in a COA

Missing or vague descriptions of testing methods.
Lack of chromatograms or visual data supporting the purity claims.
Discrepancies in reported purity percentages from different labs.
Unsigned or undated certificates.

By thoroughly reviewing these key data points, researchers can ensure they are working with reliable products.

4. What Makes Pure Health Peptides Stand Out?

At Pure Health Peptides, we go the extra mile to ensure the quality and reliability of our products. Unlike others in the industry, we:

Collaborate with MZ Biolabs and Bio Regen, both laboratories that meet the same high standards we uphold. Their use of advanced testing methods like UPLC, HPLC, UV, and MS ensures our products are tested with precision and transparency.
Ensure all products are tested using advanced methods and include detailed data such as chromatograms, impurity breakdowns, and molecular confirmations.
Proactively address industry challenges by prioritizing comprehensive and reliable certification processes.

We chose to partner with MZ Biolabs and Bio Regen, because their commitment to rigorous testing aligns with our values, and their standout practices mirror our dedication to delivering excellence.

5. How We Educate and Empower Researchers

To help researchers navigate the complexities of COAs and testing:

We Share Insights: Using examples, we highlight what to look for in a COA, including key data points and common red flags.
We Lead by Example: By ensuring our COAs are complete, transparent, and meet stringent criteria, we set a benchmark for the industry.
We Advocate for Better Standards: Our commitment to understanding and addressing testing challenges positions us as a trusted partner in the research community.

6. Partnering for Excellence

By partnering with MZ Biolabs and Bio Regen, we ensure that our products are tested and certified to the highest standards. This collaboration reflects our shared commitment to quality, transparency, and reliability. At Pure Health Peptides, we don’t just provide peptides – we provide verifiable research quality.

HOw We Test

Five measurements answer the full quality question for a chemically synthesized lyophilized peptide. The first three address the compound itself. The last two address the supply chain it travels through.

01

Identity

Does the molecule match the label?

Mass spectrometry (LC-MS or UHPLC-MS) measures the compound’s mass to within fractions of a Dalton and compares it to the theoretical mass calculated from the peptide’s amino acid sequence. A match within ≤0.1 Da confirms identity. A mismatch — even a small one — means the compound isn’t what the label claims.

02

Purity

What proportion of the sample is the labeled compound versus process-related impurities?

HPLC (or higher-resolution UHPLC) with UV detection separates the sample into discrete peaks. The labeled compound’s peak, expressed as a percentage of the total area, is the purity. Reported as a number on every COA — not an adjective.

03

QUANTITY

Is the labeled mass actually in the vial?

Verified by quantitative analytical methods that measure delivered mass against label claim. Mass verified, not estimated.

04

ENDOTOXIN

USP <85> compliant

The chemistry of solid-phase peptide synthesis involves no bacteria — but the post-synthesis chain (handling, lyophilization, vial filling, storage) does. Endotoxin testing per USP <85> uses LAL or recombinant Factor C assays to detect lipopolysaccharide residues from gram-negative bacteria, at picogram sensitivity.

05

MICROBIAL LIMITS

USP <61> / USP <62>

Same supply chain, different contaminants. USP <61> screens total aerobic counts; USP <62> tests for specified microorganisms (yeast, mold, specified pathogens). Together with endotoxin, they confirm the post-synthesis environment hasn’t introduced contamination the chemistry itself can’t account for.

HOw We Test

When you open a COA from our library, here is what each field tells you and how to evaluate it.

01

Compound and CAS number

The compound name should match the product you ordered. The CAS number is a unique chemical identifier registered in the Chemical Abstracts Service database — the same CAS number is used by every supplier and lab worldwide for a given compound.

02

Batch / Lot Number

The unique identifier for the specific production run that yielded the material in your vial. The same identifier is printed vertically along the side of your product label.

03

Sample received and analysis conducted dates

When the lab received the sample and when the analysis was performed.

04

Analytical method

The techniques used — UHPLC-MS for identity and purity, LAL or rFC assay for endotoxin per USP <85>, petrifilm/qPCR for microbial limits per USP <61>/<62>.

05

Identity test

Specification and result. The result should read “Conforms.”

06

Quantity

Specification and measured result. Slight overages (e.g., 10.6 mg measured against a 10 mg label) are normal and expected.

07

Purity

Specification (e.g., ≥99%) and measured result (e.g., 99.82%). The measured purity typically exceeds the specification — the specification is the floor, not the target.

08

Endotoxin

Specification (typically expressed as an upper limit in EU/mg) and measured result. The result should fall below the specification limit.

09

Microbial limits

Specifications for total aerobic count, total combined yeasts and molds, and absence of specified pathogens (typically per USP <61>/<62>).

10

Chromatogram (when present)

Visual output from the HPLC or UHPLC analysis. Under ISO 17025 accreditation, the institutional documentation framework guarantees the rigor of every test; the chromatogram is supporting analytical evidence rather than the primary proof. Ethos Analytics COAs report results in summary form, with the full chromatographic data retained as part of the lab’s documented record.

ReD flags in a COA

When evaluating a COA from any supplier, the following are warning signs:

01

No accreditation status disclosed for the issuing laboratory

This is the single most important red flag. A COA from a non-accredited lab is a self-issued document with no independent oversight of the methodology behind it.

02

Missing or vague description of the analytical method

A reliable COA names the specific technique used (e.g., UHPLC-MS, HPLC-UV, LAL assay) and describes the conditions of analysis.

03

No identity confirmation

Some COAs report only purity percentage, with no separate test confirming that the compound being measured is actually the labeled compound. Purity is meaningless if identity is unverified.  

04

Discrepancies in reported purity across labs or batches without explanation

Some variation between batches is normal; substantial unexplained variation suggests inconsistent methodology.

05

Unsigned or undated certificates

A COA should clearly identify the issuing lab, the analyst or certifying authority, and the date of analysis.

06

Inconsistent batch identifiers

The batch number on the COA should match the batch number on the product label.

07

No supply-chain testing on a lyophilized vialed product

For chemically synthesized lyophilized peptides, the standard appropriate panel includes endotoxin and microbial limits alongside identity, purity, and quantity. A COA that reports only the first three for a lyophilized vialed product is missing the supply-chain defense layer.

More tests on a COA does not mean better testing. The relevant question is whether the tests reported are the ones that verify quality for the manufacturing method that produced the material.

— Nisrin Samsum 
CEO, Ethos Analytics